Real-time enrollment status for this non-small cell lung cancer clinical trial
Current Status
Recruiting
Checked: July 19, 2026 at 12:40 AM UTC
| NCT Number | NCT04332367 |
| Recruiting Status | Recruiting |
| Condition | Non-small Cell Lung Cancer |
| Phase | PHASE2 |
| Target Enrollment | 59 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Abramson Cancer Center at Penn Medicine |
| Last Updated on CT.gov | June 10, 2026 (Jun 10, 2026) |
As of July 19, 2026: Clinical trial NCT04332367 is currently recruiting participants. This phase2 study for non-small cell lung cancer is actively seeking new participants at 1 location across the United States. The study is sponsored by Abramson Cancer Center at Penn Medicine. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04332367 is actively recruiting participants as of July 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04332367 was last updated Jun 10, 2026 (June 10, 2026). HelloStudys verifies this status automatically.